Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849259 · ClinicalTrials.gov registry record · NA

Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT05849259: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05849259 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05849259, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this clinical trial is to develop a dementia care intervention for persons receiving home-based primary care (HBPC) and living with dementia (PLWD) and their caregivers, and test the feasibility of implementing the intervention in HBPC practices to ultimately improve outcomes of PLWD and their caregivers. The main aims are to: * Develop and refine HBPC Dementia Care Quality at Home * Establish feasibility (primary outcome), acceptability, and fidelity of HBPC Dementia Care Quality at Home through an open-pilot trial involving two HBPC practices. Trained clinicians and staff at two HBPC practices will implement the intervention Relevant stakeholders (caregivers of PLWD, and HBPC clinicians and staff) will participate in qualitative focus groups to provide feedback on the intervention.

Primary Outcome

The percentage of identified caregivers who complete baseline assessments.

Interventions

  • OTHER Dementia Care Quality at Home

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-10-16
Est. Completion 2024-12-20
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT05849259 record still lists

NCT05849259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Dementia Care Quality at Home is the first listed.

NCT05849259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05849259 about?

NCT05849259 is a clinical study titled "Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care". The goal of this clinical trial is to develop a dementia care intervention for persons receiving home-based primary care (HBPC) and living with dementia (PLWD) and their caregivers, and test the feasibility of implementing the intervention in HBPC practices to ultimately improve outcomes of PLWD and...

What is the current status of trial NCT05849259?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-10-16. Estimated completion is 2024-12-20.

What interventions are being tested in trial NCT05849259?

The interventions under investigation include: Dementia Care Quality at Home (OTHER).

Who is sponsoring clinical trial NCT05849259?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05849259's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05849259, the US trial registry maintained by the National Library of Medicine. NCT05849259 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.